FEATURED REPORT:
The World Market for Point of Care, 10th Edition
All of the POC IVD market in one volume. Glucose, COVID-19, flu, pregnancy and fertility, FOB, cardiac markers.
Point of care has made advances and this report provides markets for them. Kalorama’s report is like many reports in one.
The next five years of Point of Care will answer the top questions about the IVD market
How can diagnostics promote wellness? How can diagnostics improve patient-provider encounters? How can tests promote better selection and stewardship of drugs? How can tests facilitate patient home or nursing home of the future? How can diagnostics ensure the next pandemic, if and when it arrives is appropriately handled? The answers to these questions in many ways rely on the success of point-of-care solutions.
And because of this contribution, Point of Care diagnostics can earn a higher pricing and larger revenue growth than economized lab-based tests. The tests covered in this report tend to grow at higher rates than overall IVD market.
Kalorama’s report provides hundreds of data points useful for business planning and forecasts scores of market segments.
Point of care is a highly competitive market. There are many corporate profiles in this report.
Instant Access to All of Kalorama’s IVD Market Research with a Subscription.
Kalorama Information is a publisher of highly-regarded in vitro diagnostics (IVD) market reports. We can count among our customers the top clinical testing companies. We also publish vaccine, life science tech, medical device reports. Our reports provide expert, real-world market sizing and considered segmentation estimates. Business planning tools you need to know where you stand and what opportunities lie ahead.
KNOWLEDGE CENTER: THE RIGHT WAY TO GO
Be ready with a Kalorama Knowledge Center Subscription, granting All Access to our elite market IVD market research reports, to every employee in your organization. With searchability, downloadable Excel sheets, figures and tables for presentations. 
With a subscription to Kalorama Information Knowledge Center, everyone in your company can have access to information when they need it Scores of other companies have already signed up with Kalorama. Your organization too can have unlimited access to the reports that have been published and will be published. Setup is easy, pricing is reasonable and includes global licensing and unlimited usage. Contact our team today to get set up.
FOR MORE INFORMATION:
https://kaloramainformation.com/market-research-subscriptions/
SUBSCRIPTION: THE WAY COMPETITIVE COMPANIES USE RESEARCH.
Buying reports is time-consuming and slow-paced. It doesn’t match the pace of business. To succeed you need a library of knowledge, so that as questions come up, you can spend time making decisions, advising team members, avoiding issues, and sizing up the competition instead of looking through report websites for information.
SHARE WITH EMPLOYEES IN YOUR ORGANIZATION
Perhaps you are in an organization with multiple employees who need market data. Marketing wants market share data. Business planning wants market opportunity sizing, Sales wants to get a head start on a lead list. Your R&D head needs crucial backup for a product launch decision. The CEO wants to know if a potential M&A target is all that or all hype.
EMAIL US: [email protected]
PHONE: (US): 703-778-3080
CONTACT US w/ Your Specific Questions and Needs. A Representative Will Contact You.
Kalorama Information KNOWLEDGE CENTER
A subscription to the Kalorama Information Knowledge Center gives you access to hundreds of reports featuring
authoritative market research on the medical and healthcare sector.
Kalorama Information provides the key market data, trends and insights you need to drive your business strategy and growth. Explore our latest research.
Biotechnology
The Worldwide Market for Mass Spectrometry in Clinical Labs, 2024$5,000.00 – $10,500.00Mass spectrometry (MS) is increasingly being integrated into clinical laboratories, revolutionizing diagnostics with its advanced sensitivity and specificity. This technology, once primarily utilized in research settings, is now making significant strides in clinical applications, particularly in areas like therapeutic drug monitoring, metabolite testing, steroid hormone analysis, and vitamin D testing. The growing demand for MS […]-
Worldwide Sequencer Market, 2023-2028$5,000.00 – $10,500.00Kalorama Information’s new comprehensive report, Worldwide Sequencer Market, 2023-2028, provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products. The report offers historical data for 2023 […]
-
The Worldwide Market for Liquid Biopsy, 6th Edition$5,000.00 – $10,000.00Liquid biopsies have emerged as a minimally invasive diagnostic tool, analyzing tumor-derived materials circulating in biological fluids to offer valuable information for cancer diagnosis, treatment, and monitoring. While tissue biopsies and imaging techniques remain standard in solid tumor diagnosis, liquid biopsies present an alternative or complementary approach, addressing some of the limitations and risks associated […]
-
The Market for RNA Sequencing, 3rd Edition$5,000.00 – $10,000.00The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of […]
Diagnostics
-
30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025 (June 2025 Update)$5,600.00 – $8,000.00Updated quarterly (four times a year) to reflect market changes Kalorama Information’s 30-Country IVD Market Atlas, 2025 provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the U.S., China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market […]
-
In Vitro Diagnostics Business Outlook, 2025 (6 Issues)$5,250.00 – $7,500.00The in vitro diagnostics (IVD) sector stands as a cornerstone of modern healthcare, empowering clinicians with the tools to detect diseases, monitor health conditions, and guide precise treatment decisions. As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well […]
- Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025$7,000.00 – $10,000.00Kalorama Information’s new report, Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025, provides an in-depth analysis of one of the most pivotal segments of the in vitro diagnostics (IVD) industry with market estimates and forecasts spanning 2024-2029. Immunoassays—diagnostic tests that detect target analytes via antibody-antigen interactions—are foundational tools in clinical laboratories and point-of-care (POC) settings, enabling […]
- Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition$8,400.00 – $12,000.00Now in its twelfth edition — Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the POC market from a global perspective with a five-year forecast. Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition provides a comprehensive analysis of the global POC diagnostics market, with forecasts extending through 2029. While traditional lab-based analyzers remain central to the in […]
Medical Devices
-
Global Market for Medical Devices, 14th Edition$3,950.00 – $7,875.00Kalorama Information’s Global Market for Medical Devices, 14th Edition provides the detailed market intelligence that industry leaders and investors need to be competitive. Purchase your copy today to stay informed and take advantage of the significant growth opportunities in the global medtech market with analysis from 2024-2029. The medtech industry is at the forefront of […]
-
Remote Patient Monitoring and Telehealth Markets, 13th Edition$5,000.00 – $10,000.00Telehealth and remote patient monitoring have become integral to improving health conditions and preventing health complications. The transformations observed during the pandemic have bolstered telemedicine and, consequently, remote patient monitoring, instilling confidence in virtual patient assessment and access to advanced technological monitoring. Since January 2019, remote patient monitoring has experienced a significant surge, and current […]
-
The Global Market for Medical Devices, 13th Edition$5,000.00 – $10,000.00The medical device industry, commonly referred to as the medtech industry, plays a pivotal role within the broader healthcare sector. This industry undergoes continuous evolution due to ongoing advancements in technology, equipment, diagnostic tools, and medical devices. These innovations have the profound impact of extending and enhancing the lives of patients, promoting longevity and well-being. […]
-
The Market for Medical Devices, 12th Edition$5,000.00 – $10,000.00The medical device industry, often referred to as the medtech industry, is an important aspect of the entire healthcare industry. The medical device industry is constantly updating and changing through the continued development of new technologies, equipment, tests and devices. Advancements in the medical device markets are life-changing and are allowing patients to live longer, […]
Pharmaceuticals
-
Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)$5,600.00 – $8,000.00The Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030) report by Kalorama Information explores the transformative potential of cell and gene therapies in modern medicine. These therapies offer groundbreaking treatments by addressing genetic causes of diseases and modulating the immune system. The report highlights the surge in […]
-
Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)$7,000.00 – $10,000.00The CGT market is evolving rapidly, with billions in investments and thousands of strategic deals shaping its trajectory. Companies that understand the landscape and anticipate future deal trends will have the competitive edge needed to thrive. Whether you are a biotech executive, investor, R&D leader, or regulatory strategist, this report provides data-driven insights to inform […]
- Cell and Gene Therapy Deals Analysis, 2021-2024$6,300.00 – $12,600.00Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 is published in two installments, the first in Q2 2024 and the second in Q4 2024. Customers who purchase the report will receive both installments. Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other […]
-
Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029$5,000.00 – $10,500.00Authoritative market research on cell therapy, gene therapy, and RNA therapy analyzing markets by disease type Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in new therapies […]
